A multidisciplinary approach with immunotherapies for advanced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a highly aggressive disease that is usually diagnosed at an advanced stage. Advanced HCC has limited treatment options and often has a poor prognosis. For the past decade, tyrosine kinase inhibitors have been the only treatments approved for advanced HCC that have s...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Liver Cancer Association
2023-09-01
|
| Series: | Journal of Liver Cancer |
| Subjects: | |
| Online Access: | http://www.e-jlc.org/upload/pdf/jlc-2023-09-04.pdf |